Focus Session

REALIZING THE POTENTIAL OF PSC-DERIVED THERAPIES: FROM RESEARCH TO CLINICAL TRANSLATION

Organized by BlueRock Therapeutics
Despite their immense potential for treating a wide range of diseases characterized by irreversible cell loss and high unmet medical needs, the broad clinical application of PSC-based stem cell therapies faces major obstacles. These hurdles include technical limitations, high costs, as well as challenges related to poor cell survival and engraftment. The purpose of this session is to provide an update on the ongoing efforts within both industry and academia aimed at overcoming significant barriers hindering the widespread adoption of PSC-based stem cell therapies in the clinic.